NCT02214420View on ClinicalTrials.gov

SMV + SOF With/Without RBV for IFN-II Patients With CHC

PHASE4CompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

October 31, 2014

Primary Completion Date

June 30, 2016

Study Completion Date

June 30, 2016

Conditions
Hepatitis C
Interventions
DRUG

Simeprevir

DRUG

Sofosbuvir

DRUG

Ribavirin

Trial Locations (3)

10029

Icahn School of Medicine at Mt. Sinai, New York

84123

Clinical Research Centers of America, LLC, Murray

92037

Scripps Clinic, La Jolla

All Listed Sponsors
collaborator

Janssen, LP

INDUSTRY

lead

SC Liver Research Consortium, LLC

OTHER

NCT02214420 - SMV + SOF With/Without RBV for IFN-II Patients With CHC | Biotech Hunter | Biotech Hunter